(Q35191584)

English

Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

bacterial isolate

1 reference

based on heuristic

inferred from title

7

object named as

Po-Ren Hsueh

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

author name string

Ching-Lan Lu

1

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Chia-Ying Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Yu-Tsung Huang

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Chun-Hsing Liao

4

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Lee-Jene Teng

5

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

John D Turnidge

6

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

language of work or name

0 references

publication date

13 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

4295-4301

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

28 July 2018

Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

28 July 2018

In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

28 July 2018

Susceptibility of urinary tract bacteria to fosfomycin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

28 July 2018

Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

28 July 2018

Fosfomycin: use beyond urinary tract and gastrointestinal infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

28 July 2018

In vitro activity of fosfomycin against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

28 July 2018

Novel Fosfomycin resistance of Pseudomonas aeruginosa clinical isolates recovered in Japan in 1996.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

28 July 2018

Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

28 July 2018

Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

28 July 2018

Single-dose fosfomycin trometamol versus multiple-dose cotrimoxazole in the treatment of lower urinary tract infections in general practice. Multicenter Group of General Practitioners

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

28 July 2018

Fosfomycin trometamol versus amoxycillin--single-dose multicenter study of urinary tract infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

28 July 2018

In vitro susceptibility testing procedures for fosfomycin tromethamine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

28 July 2018

Single-dose fosfomycin trometamol (Monuril) versus multiple-dose norfloxacin: results of a multicenter study in females with uncomplicated lower urinary tract infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

28 July 2018

In vitro fosfomycin activity in vancomycin-resistant Enterococcus faecalis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

27 September 2018

Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

27 September 2018

Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

27 September 2018

Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

27 September 2018

Antimicrobial resistance of bacterial isolates from respiratory care wards in Taiwan: a horizontal surveillance study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

27 September 2018

Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

27 September 2018

Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

27 September 2018

In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

27 September 2018

Effectiveness of fosfomycin combined with other antimicrobial agents against multidrug-resistant Pseudomonas aeruginosa isolates using the efficacy time index assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

27 September 2018

Antimicrobial susceptibilities among clinical isolates of extended-spectrum cephalosporin-resistant Gram-negative bacteria in a Taiwanese University Hospital

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

27 September 2018

In-vitro activity of fosfomycin against vancomycin-resistant enterococci

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165352

27 September 2018

Antibacterial spectrum of fosfomycin trometamol

1 reference

https://pubmed.ncbi.nlm.nih.gov/21670185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii

1 reference

https://pubmed.ncbi.nlm.nih.gov/21670185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/21670185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of fosfomycin trometamol against pathogens from urinary tract infections: a Spanish multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21670185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fosfomycin tromethamine susceptibility of outpatient urine isolates of Escherichia coli and Enterococcus faecalis from ten North American medical centres by three methods

1 reference

https://pubmed.ncbi.nlm.nih.gov/21670185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/21670185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21670185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic options for infections due to vancomycin-resistant enterococci

1 reference

https://pubmed.ncbi.nlm.nih.gov/21670185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of fosfomycin with other antimicrobial agents: in vitro and in vivo studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21670185

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.00349-11

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

release_p6mlnwkexng3nlaw4bhdy6d5gm

1 reference

https://api.fatcat.wiki/v0/release/p6mlnwkexng3nlaw4bhdy6d5gm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35191584&oldid=1940261301"